S. Iyer et al., Inhibition of tumor necrosis factor mRNA translation by a rationally designed immunomodulatory peptide, J BIOL CHEM, 275(22), 2000, pp. 17051-17057
Based on sequences of immunomodulatory peptides derived from the heavy chai
n of HLA Class I, novel immunomodulatory peptides with increased potency we
re developed by computer-aided rational design. Allotrap 1258 was character
ized in detail and shown to inhibit cell-mediated immune responses in vitro
and in vivo. Immunomodulatory activity was associated with the capability
of the peptides to modulate heme oxygenase (HO) activity. In this study we
analyzed the effect of Allotrap 1258 on cytokine expression. Allotrap 1258
inhibited concanavalin A- and lipopolysaccharide-induced human and mouse tu
mor necrosis factor (TNF) production in vitro and in vivo but had no effect
on interleukin (IL)-1, IL-2, IL-4, IL-6, or IL-10 expression. Experiments
with HO-1/KO and iNOS/KO mice showed that Allotrap 1258-mediated inhibition
of TNF was independent of HO-1 and iNOS. Quantitation of TNF protein expre
ssion and mRNA steady state levels demonstrated that Allotrap 1258-mediated
inhibition occurred at the translational level. Deletion of the AU-rich el
ement in the 3'-untranslated region (UTR) of TNF mRNA, a region known to be
involved in TNF mRNA translation, had minimal effect on Allotrap 1258-medi
ated inhibition. However, replacement of the TNF 3'-UTR with the human glob
in 3'-UTR rendered the peptide inactive. This demonstrates that besides AU-
rich elements, other sequences in the 3'-UTR of TNF mRNA are involved in tr
anslational control of TNF expression. Such sequences are necessary for All
otrap 1258 mediated inhibition of TNF production.